GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
This Quarter Return
+15.08%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$2.54B
AUM Growth
+$2.54B
(+1.7%)
Cap. Flow
-$198M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
27.59%
Holding
204
New
24
Increased
57
Reduced
106
Closed
17
Top Buys
| 1 |
Exact Sciences
EXAS
|
$27.9M |
| 2 |
ACV Auctions
ACVA
|
$18.3M |
| 3 |
Kura Sushi USA
KRUS
|
$17.5M |
| 4 |
HubSpot
HUBS
|
$15.3M |
| 5 |
SharkNinja
SN
|
$14.7M |
Top Sells
| 1 |
Zeta Global
ZETA
|
$84.6M |
| 2 |
SMAR
Smartsheet Inc.
SMAR
|
$19.6M |
| 3 |
Sprout Social
SPT
|
$19.6M |
| 4 |
Castle Biosciences
CSTL
|
$18.1M |
| 5 |
Magnite
MGNI
|
$17M |
Sector Composition
| 1 | Technology | 35.52% |
| 2 | Healthcare | 22.32% |
| 3 | Industrials | 15.28% |
| 4 | Consumer Discretionary | 8.56% |
| 5 | Communication Services | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
101
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $7.28M | 0.29% |
99,534
+6,949
| +8% | +$508K |
|
102
Mayville Engineering Co
MEC
$288M
| $7.13M | 0.28% |
338,215
+13,781
| +4% | +$291K |
|
103
10x Genomics
TXG
$1.66B
| $7.11M | 0.28% |
315,054
-18,953
| -6% | -$428K |
|
104
Revolution Medicines
RVMD
$7.43B
| $6.77M | 0.27% |
+149,359
| New | +$6.77M |
|
105
Silicon Laboratories
SLAB
$4.3B
| $6.77M | 0.27% |
58,593
+22,418
| +62% | +$2.59M |
|
106
Blue Bird Corp
BLBD
$1.83B
| $6.76M | 0.27% |
141,037
+128
| +0.1% | +$6.14K |
|
107
CCC Intelligent Solutions
CCCS
$6.34B
| $6.72M | 0.26% |
607,986
-213,106
| -26% | -$2.35M |
|
108
Agios Pharmaceuticals
AGIO
$2.36B
| $6.7M | 0.26% |
150,785
+13,947
| +10% | +$620K |
|
109
Allegro MicroSystems
ALGM
$5.52B
| $6.6M | 0.26% |
283,275
+63,871
| +29% | +$1.49M |
|
110
RxSight
RXST
$364M
| $5.93M | 0.23% |
120,046
+25,955
| +28% | +$1.28M |
|
111
Mesa Laboratories
MLAB
$338M
| $5.93M | 0.23% |
45,633
-8,791
| -16% | -$1.14M |
|
112
Boot Barn
BOOT
$5.5B
| $5.86M | 0.23% |
35,021
+1,416
| +4% | +$237K |
|
113
FIVE9
FIVN
$2.05B
| $5.85M | 0.23% |
203,446
-83,684
| -29% | -$2.4M |
|
114
Legend Biotech
LEGN
$6.64B
| $5.83M | 0.23% |
+119,591
| New | +$5.83M |
|
115
Intellia Therapeutics
NTLA
$1.26B
| $5.83M | 0.23% |
283,534
+68,624
| +32% | +$1.41M |
|
116
Cytokinetics
CYTK
$5.98B
| $5.75M | 0.23% |
108,957
-27,921
| -20% | -$1.47M |
|
117
Descartes Systems
DSGX
$8.54B
| $5.67M | 0.22% |
55,113
-10,560
| -16% | -$1.09M |
|
118
Merus
MRUS
$5.04B
| $5.66M | 0.22% |
113,251
+92,976
| +459% | +$4.65M |
|
119
Informatica
INFA
$7.6B
| $5.54M | 0.22% |
+218,977
| New | +$5.54M |
|
120
Arcus Biosciences
RCUS
$1.24B
| $5.47M | 0.22% |
357,838
-22,009
| -6% | -$337K |
|
121
Apogee Therapeutics
APGE
$2.27B
| $5.39M | 0.21% |
+91,757
| New | +$5.39M |
|
122
iRhythm Technologies
IRTC
$5.67B
| $5.38M | 0.21% |
+72,428
| New | +$5.38M |
|
123
Prothena Corp
PRTA
$452M
| $5.23M | 0.21% |
312,520
-23,140
| -7% | -$387K |
|
124
EXL Service
EXLS
$7.05B
| $5.16M | 0.2% |
135,222
-61,434
| -31% | -$2.34M |
|
125
Novanta
NOVT
$4.05B
| $5.14M | 0.2% |
28,746
+8,315
| +41% | +$1.49M |
|